ACAD
31.81
-0.89
-2.72%
AEMD
5.02
+0.09
+1.82%
APRI
0.338
+0.002
+0.6845%
ARNA
1.75
0.00
0.00%
ATEC
9.4
+0.07
+0.75%
CNAT
2
-0.01
-0.50%
CRXM
0.198
-0.062
-23.846%
CYTX
2.03
+0.02
+1.00%
DXCM
87.66
-0.14
-0.16%
GNMK
11.8
+0.92
+8.46%
HALO
12.08
+0.18
+1.51%
ILMN
181.66
+5.1
+2.89%
INNV
0.28
0.00
+0.48%
INO
9.32
+0.06
+0.65%
ISCO
1.85
0.00
0.00%
ISIS
57.56
0.00
0.00%
LGND
102.06
+0.05
+0.05%
LPTN
3.28
+0.04
+1.2377%
MBVX
4.24
+0.08
+1.92%
MEIP
1.76
+0.04
+2.33%
MNOV
7.49
+0.06
+0.81%
MRTX
6.61
+0.09
+1.38%
MSTX
0.11
+0.01
+8.91%
NBIX
50.64
+0.31
+0.62%
NUVA
66.66
+0.91
+1.38%
ONCS
1.71
0.00
0.00%
ONVO
3.79
+0.02
+0.53%
OREX
3.32
+0.12
+3.75%
OTIC
18.19
+0.93
+5.39%
QDEL
22.09
+1.2
+5.74%
RCPT
231.96
0.00
0.00%
RGLS
3.3
+0.01
+0.30%
RMD
64.79
+0.58
+0.90%
SPHS
3.11
+0.03
+0.97%
SRNE
7.74
+0.14
+1.84%
TROV
4.49
+0.21
+4.91%
VICL
3.04
-0.03
-0.98%
VOLC
18
0.00
0.00%
ZGNX
11.43
+0.74
+6.92%
ACAD
31.81
-0.89
-2.72%
AEMD
5.02
+0.09
+1.82%
APRI
0.338
+0.002
+0.6845%
ARNA
1.75
0.00
0.00%
ATEC
9.4
+0.07
+0.75%
CNAT
2
-0.01
-0.50%
CRXM
0.198
-0.062
-23.846%
CYTX
2.03
+0.02
+1.00%
DXCM
87.66
-0.14
-0.16%
GNMK
11.8
+0.92
+8.46%
HALO
12.08
+0.18
+1.51%
ILMN
181.66
+5.1
+2.89%
INNV
0.28
0.00
+0.48%
INO
9.32
+0.06
+0.65%
ISCO
1.85
0.00
0.00%
ISIS
57.56
0.00
0.00%
LGND
102.06
+0.05
+0.05%
LPTN
3.28
+0.04
+1.2377%
MBVX
4.24
+0.08
+1.92%
MEIP
1.76
+0.04
+2.33%
MNOV
7.49
+0.06
+0.81%
MRTX
6.61
+0.09
+1.38%
MSTX
0.11
+0.01
+8.91%
NBIX
50.64
+0.31
+0.62%
NUVA
66.66
+0.91
+1.38%
ONCS
1.71
0.00
0.00%
ONVO
3.79
+0.02
+0.53%
OREX
3.32
+0.12
+3.75%
OTIC
18.19
+0.93
+5.39%
QDEL
22.09
+1.2
+5.74%
RCPT
231.96
0.00
0.00%
RGLS
3.3
+0.01
+0.30%
RMD
64.79
+0.58
+0.90%
SPHS
3.11
+0.03
+0.97%
SRNE
7.74
+0.14
+1.84%
TROV
4.49
+0.21
+4.91%
VICL
3.04
-0.03
-0.98%
VOLC
18
0.00
0.00%
ZGNX
11.43
+0.74
+6.92%
Home » Archive by Category

Syndication

Brewmaster (Chico, CA)

September 30, 2016 – 1:06 pm

Is your passion brewing beautifully crafted beers?
Ours is.
At Sierra Nevada Brewing Co., we have spent the last 36 years pushing the boundaries of craft beer and chasing perfection.
Our current Brewmaster at our Chico brewery has announced his re […

Health and Safety Technician – KellyMitchell – San Diego, CA

September 30, 2016 – 12:28 pm

In this role you’ll have the opportunity to directly support the company’s global Biotechnology pipeline. KellyMitchell matches the best IT and business talent…
From KellyMitchell – Fri, 30 Sep 2016 19:28:18 GMT – View all San Diego jobs

Media Room Technician (Sorrento Mesa)

September 30, 2016 – 10:02 am

We are a San Diego-based biotech company that provides cell cultures and cell biology products for research use. We are seeking candidates to fill the Media Room Technician role. The Media Room Technician’s work directly impacts the life sciences com […

Media Room Technician (Sorrento Mesa)

September 30, 2016 – 10:02 am

We are a San Diego-based biotech company that provides cell cultures and cell biology products for research use. We are seeking candidates to fill the Media Room Technician role. The Media Room Technician’s work directly impacts the life sciences com […

San Diego – Patent Technical Specialist/Patent Agent Trainee – Dentons – San Diego, CA

September 30, 2016 – 9:20 am

This is an excellent chance to be part of a dedicated team and work on patent matters related to biotechnology, including molecular biology, immunology and…From Dentons – Fri, 30 Sep 2016 16:20:56 GMT – View all San Diego jobs

Technical Sales Executive (Oceanside)

September 30, 2016 – 8:53 am

Lifeline Cell Technology (Lifeline) specializes in the development and manufacture of purified primary human cells and optimized reagents for cell culture.
Our technical account representatives take pride in providing superior customer and technical […

Technical Sales Executive (Oceanside)

September 30, 2016 – 8:53 am

Lifeline Cell Technology (Lifeline) specializes in the development and manufacture of purified primary human cells and optimized reagents for cell culture.
Our technical account representatives take pride in providing superior customer and technical […

Laboratory Director – Health Care Organization in La Jolla and Del Mar – Del Mar, CA

September 30, 2016 – 8:37 am

An advanced degree in life Sciences, Chemistry, or related field and 10 years of experience in pharmaceuticals and/or biotechnology industry with 5 years in…From Indeed – Fri, 30 Sep 2016 15:37:52 GMT – View all Del Mar jobs

Misonix Features BoneScalpel(TM) and SonaStar(TM) Systems at Congress of Neurological Surgeons (“CNS”)

September 30, 2016 – 7:32 am

FARMINGDALE, N.Y., Sept. 30, 2016 /PRNewswire/ — Misonix, Inc. (NASDAQ: MSON), an international surgical device company that designs, manufactures and markets innovative therapeutic ultrasonic products for spine surgery, neurosurgery, wound debridement, skull based surgery, laparoscopic surgery and other surgical applications, announced its participation at the recent Congress of Neurological Surgeons (“CNS”) Annual Meeting in San Diego, CA, which took place on September 24-28, 2016.

At this year’s CNS meeting, Misonix featured its BoneScalpel with ultrasonic technology and its newest product, the SonaStar Ultrasonic Surgical Aspiration System. The CNS meeting represents a premier forum for neurosurgeons and residents to share best practices and learn about the newest procedures, approaches, and technologies in all neurosurgical subspecialties. There were more than 2,000 attendees at this year’s event. Activity at the Misonix exhibit was noticeably greater over this year’s three-day period compared to the 2015 CNS event. Visitors to the exhibit were introduced to the BoneScalpel and SonaStar systems and provided the opportunity for hands-on demonstrations.

BoneScalpel with ultrasonic technology is being increasingly adopted by spine surgeons for the purpose of making precise and safe bone cuts during challenging spine surgeries. Common surgical applications successfully treated with BoneScalpel include deformity cases, laminectomies and transforaminal lumbar interbody fusion (“TLIF”) procedures. The SonaStar Ultrasonic Aspirator is an advanced ultrasonic aspiration system which enables efficient, precise soft tissue aspiration and powerful removal of fibrous and osseous structures as required.

“The CNS Meeting is an important meeting for Misonix as we look to further expand our commercial footprint in the neurosurgery community and more broadly introduce our ultrasound technologies. I am pleased to see that a substantial number of neurosurgeons who visited with our onsite team in the exhibit have already requested system evaluations at their respective institutions,” said Scott Ludecker, Senior Vice President of Global Sales and Marketing. 

Commenting further, Stavros Vizirgianakis, Interim Chief Executive Officer of Misonix, offered, “We’re excited to see the significant level of interest surgeons are exhibiting toward our unique platform technologies. Events like the CNS meeting are outstanding forums to allow new surgeons to gain hands-on experience with our products.”

About Misonix
Misonix, Inc. designs, develops, manufactures and markets therapeutic ultrasonic medical devices. Misonix’s therapeutic ultrasonic platform is the basis for several innovative medical technologies. Addressing a combined market estimated to be in excess of $1.5 billion annually; Misonix’s proprietary ultrasonic medical devices are used in spine surgery, neurosurgery, orthopedic surgery, wound debridement, cosmetic surgery, laparoscopic surgery, and other surgical and medical applications.  Additional information is available on the Company’s Web site at www.misonix.com.

Safe Harbor Statement
With the exception of historical information contained in this press release, content herein may contain “forward looking statements” that are made pursuant to the Safe Harbor Provisions of the Private Securities Litigation Reform Act of 1995. These statements are based on management’s current expectations and are subject to uncertainty and changes in circumstances. Investors are cautioned that forward-looking statements involve risks and uncertainties that could cause actual results to differ materially from the statements made. These factors include general economic conditions, delays and risks associated with the performance of contracts, risks associated with international sales and currency fluctuations, uncertainties as a result of research and development, acceptable results from clinical studies, including publication of results and patient/procedure data with varying levels of statistical relevancy, risks involved in introducing and marketing new products, potential acquisitions, consumer and industry acceptance, litigation and/or court proceedings, including the timing and monetary requirements of such activities, the timing of finding strategic partners and implementing such relationships, regulatory risks including approval of pending and/or contemplated 510(k) filings, the ability to achieve and maintain profitability in the Company’s business lines, and other factors discussed in the Company’s Annual Report on Form 10-K, subsequent Quarterly Reports on Form 10-Q and Current Reports on Form 8-K. The Company disclaims any obligation to update its forward-looking relationships.

Corporate Contact

Investor Contact

Misonix Contact:

Joe Diaz

Richard Zaremba

Lytham Partners

631-694-9555

602-889-9700    

invest@misonix.com 

info@misonix.com

Logo – http://photos.prnewswire.com/prnh/20160201/328020LOGO

 

SOURCE Misonix, Inc.

Bio Roundup: CAR-T & Migraine Races, Intra-Cellular, Rockefeller & More

September 30, 2016 – 7:25 am

The presidential race captivated millions of TV viewers this week as the first debate took place in Hofstra. But biotech watchers had other races on their mind. Who will be first to market with a new…

[[Click headline to continue reading.]]